Fresh analysis reveals that patients who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt conventional diet and exercise programs.
Published data in a leading health publication demonstrates that while obese people can lose substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"People purchasing such treatments must be cognizant of the risk of rapid rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery suggests a return to original weight in about one and a half years.
Analyzing Approaches
The study, which examined dozens of studies involving thousands of patients, contrasted the results of these new drugs with other pills.
Scientists note that individuals who lose weight through dieting typically experience a less rapid creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Doctors believe the way of the drugs accounts for the accelerated rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement leads to hunger is uncontrolled, making overeating a significant risk."
An Ongoing Issue?
The NHS advise the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.
Many experts say that, due to the significant potential of relapse, the therapy is often ongoing.
This opinion is supported by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," comparing it to managing conditions like high blood pressure.
Patient Experiences
Individuals who have discontinued the jabs describe a sudden resurgence of cravings.
"It was like a switch activating and you become extremely hungry," said an individual.
The struggle is exacerbated if patients have not established sustainable dietary or behavioural changes during therapy.
Widespread Adoption
Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among women than males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Ultimately, researchers caution that while these medications are effective agents for weight loss, they are not a permanent solution and maintained weight loss hinges on ongoing behavioural changes.
